Botulinum toxin in the treatment of facial dyskinesias.
Patients with hemifacial spasm (N = 25), blepharospasm (n = 8), and benign eyelid fasciculation (n = 2) were treated with botulinum toxin injections (PHLS, Porton Down, England). All patients reported substantial symptomatic relief. Marked improvement was seen in fifteen patients with hemifacial spasm and six patients with blepharospasm. Benign eyelid fasciculation was completely abolished. Beneficial effects was evident two to three days after injections, became maximum at one week, and remained effective for up to six months. Side effects were transitory and mild. They included periorbital edema, mild diplopia, ptosis and facial weakness. Only in two patients was ptosis unacceptable. Severity of side effects was dose-related. Reinjections had similar efficacy. Botulinum toxin therapy is a safe and effective treatment for these facial dyskinesias and should be considered a viable alternative to surgical procedures.
Chong
P N
PN
Department of Medicine, National University Hospital, Singapore.
Ong
B
B
Chan
R
R
D000328:Adult; D000368:Aged; D001764:Blepharospasm / Q000188:drug therapy* / Q000503:physiopathology; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005141:Eyelid Diseases / Q000188:drug therapy* / Q000503:physiopathology; D005152:Facial Muscles; D005207:Fasciculation / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D013035:Spasm / Q000188:drug therapy* / Q000503:physiopathology; D014743:Videotape Recording
D001905:Botulinum Toxins